65 results
424B5
ABEO
Abeona Therapeutics Inc
23 Dec 19
Prospectus supplement for primary offering
5:17pm
licensed MuGard to RHEI Pharmaceuticals, N.V. for China and other Southeast Asian countries in 2010; Hanmi Pharmaceutical Co. Ltd. for South Korea
424B5
ABEO
Abeona Therapeutics Inc
20 Dec 19
Prospectus supplement for primary offering
12:00am
, N.V. for China and other Southeast Asian countries in 2010; Hanmi Pharmaceutical Co. Ltd. for South Korea in 2014; and Norgine B.V. for the European
424B5
jfon7qurnsa40chh3q23
17 Aug 18
Prospectus supplement for primary offering
5:19pm
424B5
r7pnd 3oyo0guep3a79
27 Oct 16
Prospectus supplement for primary offering
12:00am